Skip to main content

Advertisement

Log in

Atypical Cutaneous Presentations of Sarcoidosis: Two Case Reports and Review of the Literature

  • Autoimmunity (TK Tarrant, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The goal of this review is to provide the reader with an updated summary of the cutaneous manifestations of systemic sarcoidosis, with a particular emphasis on the predilection of sarcoidosis for scars, tattoos, and other areas of traumatized skin.

Recent Findings

While the mechanism underlying the propensity for traumatized skin to develop sarcoidosis lesions remains unclear, several theories have been proposed including the idea that cutaneous sarcoidosis represents an exuberant, antigen-driven foreign-body response, as well as the theory that traumatized skin represents an immunocompromised district with altered local immune trafficking and neural signaling.

Summary

In this review, we present two cases in which the development of cutaneous lesions in scars and tattoos was integral to the diagnosis of systemic sarcoidosis. We then review the various cutaneous manifestations of systemic sarcoidosis, the clinical characteristics and differential diagnosis of scar and tattoo sarcoidosis, the proposed mechanism by which traumatized skin is prone to developing sarcoidosis lesions, and current treatments for cutaneous sarcoidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Figure 2

Similar content being viewed by others

Abbreviations

EN:

Erythema nodosum

TNF:

Tumor necrosis factor

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL. Disease burden and variability in sarcoidosis. Annals of the American Thoracic Society. 2017;14(Supplement_6):S421–S8. https://doi.org/10.1513/AnnalsATS.201707-564OT.

    Article  PubMed  Google Scholar 

  2. Iannuzzi MC, Rybicki BA, Teirstein AS. Medical progress: sarcoidosis. New Engl J Med. 2007;357(21):2153–65. https://doi.org/10.1056/Nejmra071714.

    Article  PubMed  CAS  Google Scholar 

  3. English JC, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol. 2001;44(5):725–43. https://doi.org/10.1067/mjd.2001.114596.

    Article  PubMed  Google Scholar 

  4. •• Wanat KA, Rosenbach M. Cutaneous sarcoidosis. Clin Chest Med. 2015;36(4):685–702. https://doi.org/10.1016/j.ccm.2015.08.010. A review of the clinical presentation, diagnosis, and management of cutaneous sarcoidosis.

    Article  PubMed  Google Scholar 

  5. Ruocco E, Gambardella A, Langella GG, Lo Schiavo A, Ruocco V. Cutaneous sarcoidosis: an intriguing model of immune dysregulation. Int J Dermatol. 2015;54(1):1–12. https://doi.org/10.1111/ijd.12566.

    Article  PubMed  Google Scholar 

  6. Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Resp Med. 2003;97(8):978–82. https://doi.org/10.1016/S0954-6111(03)00127-6.

    Article  Google Scholar 

  7. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983;52(208):525–33.

    PubMed  CAS  Google Scholar 

  8. O’Regan A, Berman JS. Sarcoidosis. Ann Intern Med 2012;156(9):ITC5-1, ITC5-2, ITC5-3, ITC5-4, ITC5-, ITC-6, ITC5-7, ITC5-8, ITC5-9, ITC5-10, ITC5-1, ITC5-2, ITC5-3, ITC5-4, ITC5-5; quiz ITC5-6. doi:https://doi.org/10.7326/0003-4819-156-9-201205010-01005, ITC5.

  9. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist. part II Extracutaneous Disease J Am Acad Dermatol. 2012;66(5):719. e1-10; quiz 29-30–719.e10. https://doi.org/10.1016/j.jaad.2012.02.003.

    Article  PubMed  Google Scholar 

  10. Marcoval J, Mana J, Rubio M. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol. 2011;36(7):739–44. https://doi.org/10.1111/j.1365-2230.2011.04128.x.

    Article  PubMed  CAS  Google Scholar 

  11. Yanardag H, Pamuk ON, Pamuk GE. Lupus pernio in sarcoidosis: clinical features and treatment outcomes of 14 patients. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases. 2003;9(2):72–6. https://doi.org/10.1097/01.RHU.0000062509.01658.d1.

    Article  Google Scholar 

  12. Mana J, Marcoval J, Graells J, Salazar A, Peyri J, Pujol R. Cutaneous involvement in sarcoidosis—relationship to systemic disease. Arch Dermatol. 1997;133(7):882–8. https://doi.org/10.1001/archderm.133.7.882.

    Article  PubMed  CAS  Google Scholar 

  13. Mangas C, Fernandez-Figueras MT, Fite E, Fernandez-Chico N, Sabat M, Ferrandiz C. Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis. J Cutan Pathol. 2006;33(12):772–7. https://doi.org/10.1111/j.1600-0560.2006.00563.x.

    Article  PubMed  Google Scholar 

  14. Selim A, Ehrsam E, Atassi MB, Khachemoune A. Scar sarcoidosis: a case report and brief review. Cutis. 2006;78(6):418–22.

    PubMed  Google Scholar 

  15. Zhao S, Wang Q, Cheng B, Zhu XF. Rare scar sarcoidosis: a case report. Experimental and Therapeutic Medicine. 2017;13(4):1535–7. https://doi.org/10.3892/etm.2017.4123.

    Article  PubMed  PubMed Central  Google Scholar 

  16. MacGregor G. Cutaneous sarcoidosis in venepuncture sites. Br Med J. 1973;1(5849):357.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Cecchi R, Giomi A. Scar sarcoidosis following herpes zoster. Journal of the European Academy of Dermatology and Venereology: JEADV. 1999;12(3):280–2.

    Article  PubMed  CAS  Google Scholar 

  18. Veien NK, Stahl D, Brodthagen H. Cutaneous sarcoidosis in Caucasians. J Am Acad Dermatol. 1987;16(3 Pt 1):534–40.

    Article  PubMed  CAS  Google Scholar 

  19. Lubeck G, Epstein E. Complications of tattooing. California Medicine. 1952;76(2):83–5.

    PubMed  PubMed Central  CAS  Google Scholar 

  20. • Sepehri M, Carlsen KH, Serup J. Papulo-nodular reactions in black tattoos as markers of sarcoidosis: study of 92 tattoo reactions from a hospital material. Dermatology. 2016;232(6):679–86. https://doi.org/10.1159/000453315. A review of 92 papulo-nodular tattoo reactions demonstrating that almost a third of these reactions were diagnosed with cutaneous or systemic sarcoidosis, particularly when the “rush phenomenon” is present.

    Article  PubMed  Google Scholar 

  21. Torres LK, Faiz SA. Tattoos and Sarcoidosis. New Engl J Med. 2014;370(23):E34. https://doi.org/10.1056/Nejmicm1215331.

    Article  PubMed  CAS  Google Scholar 

  22. Ayoola R, Mansour W, Gujral J. Tattoo rash. JAMA. 2015;313(17):1747–8. https://doi.org/10.1001/jama.2015.0990.

    Article  PubMed  Google Scholar 

  23. Simunovic C, Shinohara MM. Complications of decorative tattoos: recognition and management. Am J Clin Dermatol. 2014;15(6):525–36. https://doi.org/10.1007/s40257-014-0100-x.

    Article  PubMed  Google Scholar 

  24. • Islam PS, Chang C, Selmi C, Generali E, Huntley A, Teuber SS, et al. Medical complications of tattoos: a comprehensive review. Clin Rev Allerg Immu. 2016;50(2):273–86. https://doi.org/10.1007/s12016-016-8532-0. A review of the infectious and non-infectious complications of tattoos including tattoo sarcoidosis.

    Article  Google Scholar 

  25. Morales-Callaghan AM, Aguilar-Bernier M, Martinez-Garcia G, Miranda-Romero A. Sarcoid granuloma on black tattoo. J Am Acad Dermatol. 2006;55(5):S71–S3. https://doi.org/10.1016/j.jaad.2005.12.022.

    Article  PubMed  Google Scholar 

  26. Val-Bernal JF, Sanchez-Quevedo MC, Corral J, Campos A. Cutaneous sarcoidosis and foreign bodies. An electron probe roentgenographic microanalytic study. Archives of Pathology & Laboratory Medicine. 1995;119(5):471–4.

    CAS  Google Scholar 

  27. Walsh NMG, Hanly JG, Tremaine R, Murray S. Cutaneous sarcoidosis and foreign-bodies. Am J Dermatopath. 1993;15(3):203–7. https://doi.org/10.1097/00000372-199306000-00002.

    Article  PubMed  CAS  Google Scholar 

  28. Marcoval J, Mana J, Moreno A, Gallego I, Fortuno Y, Peyri M. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol. 2001;137(4):427–30.

    PubMed  CAS  Google Scholar 

  29. Munro CS, Mitchell DN. The Kveim response—still useful, still a puzzle. Thorax. 1987;42(5):321–31. https://doi.org/10.1136/Thx.42.5.321.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Reich JM. On the nature of sarcoidosis. Eur J Intern Med. 2012;23(2):105–9. https://doi.org/10.1016/j.ejim.2011.09.011.

    Article  PubMed  Google Scholar 

  31. Hirsch JG, Cohn ZA, Morse SI, Schaedler RW, Siltzbach LE, Ellis JT, et al. Evaluation of the Kveim reaction as a diagnostic test for sarcoidosis. N Engl J Med. 1961;265:827–30. https://doi.org/10.1056/NEJM196110262651703.

    Article  PubMed  CAS  Google Scholar 

  32. Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR. Selection of oligoclonal V-beta-specific T-cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol. 1995;154(3):1450–60.

    PubMed  CAS  Google Scholar 

  33. Chen ES, Moller DR. Etiologies of sarcoidosis. Clin Rev Allerg Immu. 2015;49(1):6–18. https://doi.org/10.1007/s12016-015-8481-z.

    Article  CAS  Google Scholar 

  34. Saidha S, Sotirchos ES, Eckstein C. Etiology of sarcoidosis: does infection play a role? The Yale Journal of Biology and Medicine. 2012;85(1):133–41.

    PubMed  PubMed Central  Google Scholar 

  35. Ruocco V, Brunetti G, Puca RV, Ruocco E. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol. 2009;23(12):1364–73. https://doi.org/10.1111/j.1468-3083.2009.03345.x.

    Article  CAS  Google Scholar 

  36. •• Ruocco V, Ruocco E, Piccolo V, Brunetti G, Guerrera LP, Wolf R. The immunocompromised district in dermatology: a unifying pathogenic view of the regional immune dysregulation. Clin Dermatol. 2014;32(5):569–76. https://doi.org/10.1016/j.clindermato1.2014.04.004. A review of the immunocompromised district as a way to describe regions of altered immune regulation in traumatized skin.

    Article  PubMed  Google Scholar 

  37. Lee R, Saardi KM, Schwartz RA. Lymphedema-related angiogenic tumors and other malignancies. Clin Dermatol. 2014;32(5):616–20. https://doi.org/10.1016/j.clindermato1.2014.04.008.

    Article  PubMed  Google Scholar 

  38. Ruocco V, Sangiuliano S, Brunetti G, Ruocco E. Beyond zoster: sensory and immune changes in zoster-affected dermatomes: a review. Acta Derm-Venereol. 2012;92(4):378–82. https://doi.org/10.2340/00015555-1284.

    Article  PubMed  Google Scholar 

  39. Ruocco V, Ruocco E, Ghersetich I, Bianchi B, Lotti T. Isotopic response after herpesvirus infection: an update. J Am Acad Dermatol. 2002;46(1):90–4. https://doi.org/10.1067/mjd.2002.118362.

    Article  PubMed  Google Scholar 

  40. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist. Part I Cutaneous Disease J Am Acad Dermatol. 2012;66(5):699. e1-18; quiz 717-8–699.e18. https://doi.org/10.1016/j.jaad.2011.11.965.

    Article  PubMed  Google Scholar 

  41. Wanat KA, Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol. 2014;15(4):283–97. https://doi.org/10.1007/s40257-014-0079-3.

    Article  PubMed  Google Scholar 

  42. Green JJ, Lawrence N, Heymann WR. Generalized ulcerative sarcoidosis induced by therapy with the flashlamp-pumped pulsed dye laser. Arch Dermatol. 2001;137(4):507–8.

    PubMed  CAS  Google Scholar 

  43. Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol. 2012;8(1):95–103. https://doi.org/10.1586/eci.11.84.

    Article  PubMed  Google Scholar 

  44. Droitcourt C, Rybojad M, Porcher R, Juillard C, Cosnes A, Joly P, et al. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis. Chest. 2014;146(4):1046–54. https://doi.org/10.1378/chest.14-0015.

    Article  PubMed  Google Scholar 

  45. Baughman RP, Judson MA, Lower EE, Drent M, Costabel U, Flavin S, et al. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases: Official Journal of WASOG. 2016;32(4):289–95.

    Google Scholar 

  46. •• Pariser RJ, Paul J, Hirano S, Torosky C, Smith M. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol. 2013;68(5):765–73. https://doi.org/10.1016/j.jaad.2012.10.056. A trial demonstrating the efficacy of infliximab in treating cutaneous sarcoidosis.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David L. Leverenz.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Informed Consent

Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Autoimmunity

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leverenz, D.L., Henderson, C. & Shah, A. Atypical Cutaneous Presentations of Sarcoidosis: Two Case Reports and Review of the Literature. Curr Allergy Asthma Rep 18, 40 (2018). https://doi.org/10.1007/s11882-018-0794-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-018-0794-6

Keywords

Navigation